Latest headcount
17
YoY change
0.0%
Headcount CAGR
+19.5%
Revenue / employee
$2.56K
Employee count history for Relmada Therapeutics
| Fiscal year | Employees |
|---|---|
| 2013 | 2 |
| 2015 | 11 |
| 2016 | 6 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 14 |
| 2021 | 10 |
| 2022 | 14 |
| 2023 | 20 |
| 2024 | 17 |
| 2025 | 17 |
Earnings per employee for Relmada Therapeutics
Annual net income divided by reported headcount, normalized to US dollars; years with a net loss dip below zero.
| Fiscal year | Earnings per employee (USD) |
|---|---|
| 2013 | -$22.5K |
| 2015 | -$1.89M |
| 2016 | -$496K |
| 2017 | -$2.1M |
| 2018 | -$2.99M |
| 2019 | -$4.33M |
| 2020 | -$4.25M |
| 2021 | -$12.6M |
| 2022 | -$11.2M |
| 2023 | -$4.94M |
| 2024 | -$4.7M |
| 2025 | -$3.38M |
Employee count history for Relmada Therapeutics (RLMD)
Annual figures come from annual reports (10-K, or 20-F/40-F for foreign filers); interim rows reflect headcount disclosed in periodic filings. Year-over-year change compares each filing with the prior year's equivalent. Revenue and earnings per employee are annual figures normalized to US dollars.
- 2025170.0%
- 202417-15.0%
- 202320+42.9%
- 202214+40.0%
- 202110-28.6%
- 202014+250.0%
- 20194+33.3%
- 201830.0%
- 20173-50.0%
- 20166-45.5%
- 201511—
- 20132—
About Relmada Therapeutics's employee count
Relmada Therapeutics (RLMD) employed 17 people in fiscal year 2025, based on its most recent annual report. That headcount was unchanged from 17 a year earlier.
Across the 2013–2025 period, the company's reported workforce went from 2 to 17 employees — a compound annual growth rate (CAGR) of +19.5% per year.
Relmada Therapeutics generated about $2.56K of revenue and -$3.38M of net income per employee in its latest annual period. Revenue and earnings per employee gauge how efficiently a company turns headcount into output, and are most telling when tracked over time or compared with peers in the same industry.
Frequently asked questions
Test yourself on RLMD
Employees — 10 rounds, every one of them RLMD against another company. Leave whenever you like.
Practice run — it doesn’t move your skill rating and doesn’t touch the leaderboards. Misses do go into your review queue.
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.